According to A Latest intelligence report published by Market IntelliX, the global market for Biosimilars Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Biosimilars Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Biosimilars Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Monoclonal Antibodies segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Biosimilars Drug include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius, Innovent Biologics, Jiangsu Hengrui, Gan&Lee, Tonghua Dongbao and United Laboratory, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.

This report aims to provide a comprehensive study of the global market for Biosimilars Drug. Report Highlights:

(1) Global Biosimilars Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Biosimilars Drug market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Biosimilars Drug market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Biosimilars Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Biosimilars Drug segment by type and by application and regional segment by type and by application.

(6) Biosimilars Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Monoclonal Antibodies

Insulin

Others

Market segment by application, can be divided into

Hospital

Retail Pharmacy

Other

Market segment by players, this report covers

Qilu Pharmaceutical

Bio-Thera

Zhejiang Hisun

Shanghai Henlius

Innovent Biologics

Jiangsu Hengrui

Gan&Lee

Tonghua Dongbao

United Laboratory

3SBIO

Luye Pharma

Celltrion

Pfizer

Novartis

Dr Reddy’s

Celgen Biopharma

Eli Lilly

Sanofi

Geropharm

Biocon

Wockhardt

1 Market Overview

1.1 Product Overview and Scope of Biosimilars Drug

1.2 Global Biosimilars Drug Market Size and Forecast

1.3 China Biosimilars Drug Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Biosimilars Drug Share in Global Market, 2018-2029

1.4.2 Biosimilars Drug Market Size: China VS Global, 2018-2029

1.5 Biosimilars Drug Market Dynamics

1.5.1 Biosimilars Drug Market Drivers

1.5.2 Biosimilars Drug Market Restraints

1.5.3 Biosimilars Drug Industry Trends

1.5.4 Biosimilars Drug Industry Policy

2 Global Competitive Situation by Company

2.1 Global Biosimilars Drug Revenue by Company (2018-2023)

2.2 Global Biosimilars Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Biosimilars Drug Concentration Ratio

2.4 Global Biosimilars Drug Mergers & Acquisitions, Expansion Plans

2.5 Global Biosimilars Drug Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Biosimilars Drug Revenue by Company (2018-2023)

3.2 China Biosimilars Drug Biosimilars Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Biosimilars Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Biosimilars Drug Industry Chain

4.2 Biosimilars Drug Upstream Analysis

4.3 Biosimilars Drug Midstream Analysis

4.4 Biosimilars Drug Downstream Analysis

5 Sights by Type

5.1 Biosimilars Drug Classification

5.1.1 Monoclonal Antibodies

5.1.2 Insulin

5.1.3 Others

5.2 By Type, Global Biosimilars Drug Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Biosimilars Drug Revenue, 2018-2029

6 Sights by Application

6.1 Biosimilars Drug Segment by Application

6.1.1 Hospital

6.1.2 Retail Pharmacy

6.1.3 Other

6.2 By Application, Global Biosimilars Drug Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Biosimilars Drug Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Biosimilars Drug Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Biosimilars Drug Market Size, 2018-2029

7.3 North America

7.3.1 North America Biosimilars Drug Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Biosimilars Drug Market Size Market Share

7.4 Europe

7.4.1 Europe Biosimilars Drug Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Biosimilars Drug Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Biosimilars Drug Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Biosimilars Drug Market Size Market Share

7.6 South America

7.6.1 South America Biosimilars Drug Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Biosimilars Drug Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Biosimilars Drug Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Biosimilars Drug Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Biosimilars Drug Market Size, 2018-2029

8.3.2 By Company, U.S. Biosimilars Drug Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Biosimilars Drug Market Size, 2018-2029

8.4.2 By Company, Europe Biosimilars Drug Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Biosimilars Drug Market Size, 2018-2029

8.5.2 By Company, China Biosimilars Drug Revenue Market Share, 2018-2023

8.5.3 By Type, China Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Biosimilars Drug Market Size, 2018-2029

8.6.2 By Company, Japan Biosimilars Drug Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Biosimilars Drug Market Size, 2018-2029

8.7.2 By Company, South Korea Biosimilars Drug Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Biosimilars Drug Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Biosimilars Drug Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Biosimilars Drug Market Size, 2018-2029

8.9.2 By Company, India Biosimilars Drug Revenue Market Share, 2018-2023

8.9.3 By Type, India Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Biosimilars Drug Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Biosimilars Drug Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Qilu Pharmaceutical

9.1.1 Qilu Pharmaceutical Company Information, Head Office, Market Area and Industry Position

9.1.2 Qilu Pharmaceutical Company Profile and Main Business

9.1.3 Qilu Pharmaceutical Biosimilars Drug Models, Specifications and Application

9.1.4 Qilu Pharmaceutical Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.1.5 Qilu Pharmaceutical Recent Developments

9.2 Bio-Thera

9.2.1 Bio-Thera Company Information, Head Office, Market Area and Industry Position

9.2.2 Bio-Thera Company Profile and Main Business

9.2.3 Bio-Thera Biosimilars Drug Models, Specifications and Application

9.2.4 Bio-Thera Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.2.5 Bio-Thera Recent Developments

9.3 Zhejiang Hisun

9.3.1 Zhejiang Hisun Company Information, Head Office, Market Area and Industry Position

9.3.2 Zhejiang Hisun Company Profile and Main Business

9.3.3 Zhejiang Hisun Biosimilars Drug Models, Specifications and Application

9.3.4 Zhejiang Hisun Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.3.5 Zhejiang Hisun Recent Developments

9.4 Shanghai Henlius

9.4.1 Shanghai Henlius Company Information, Head Office, Market Area and Industry Position

9.4.2 Shanghai Henlius Company Profile and Main Business

9.4.3 Shanghai Henlius Biosimilars Drug Models, Specifications and Application

9.4.4 Shanghai Henlius Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.4.5 Shanghai Henlius Recent Developments

9.5 Innovent Biologics

9.5.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position

9.5.2 Innovent Biologics Company Profile and Main Business

9.5.3 Innovent Biologics Biosimilars Drug Models, Specifications and Application

9.5.4 Innovent Biologics Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.5.5 Innovent Biologics Recent Developments

9.6 Jiangsu Hengrui

9.6.1 Jiangsu Hengrui Company Information, Head Office, Market Area and Industry Position

9.6.2 Jiangsu Hengrui Company Profile and Main Business

9.6.3 Jiangsu Hengrui Biosimilars Drug Models, Specifications and Application

9.6.4 Jiangsu Hengrui Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.6.5 Jiangsu Hengrui Recent Developments

9.7 Gan&Lee

9.7.1 Gan&Lee Company Information, Head Office, Market Area and Industry Position

9.7.2 Gan&Lee Company Profile and Main Business

9.7.3 Gan&Lee Biosimilars Drug Models, Specifications and Application

9.7.4 Gan&Lee Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.7.5 Gan&Lee Recent Developments

9.8 Tonghua Dongbao

9.8.1 Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position

9.8.2 Tonghua Dongbao Company Profile and Main Business

9.8.3 Tonghua Dongbao Biosimilars Drug Models, Specifications and Application

9.8.4 Tonghua Dongbao Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.8.5 Tonghua Dongbao Recent Developments

9.9 United Laboratory

9.9.1 United Laboratory Company Information, Head Office, Market Area and Industry Position

9.9.2 United Laboratory Company Profile and Main Business

9.9.3 United Laboratory Biosimilars Drug Models, Specifications and Application

9.9.4 United Laboratory Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.9.5 United Laboratory Recent Developments

9.10 3SBIO

9.10.1 3SBIO Company Information, Head Office, Market Area and Industry Position

9.10.2 3SBIO Company Profile and Main Business

9.10.3 3SBIO Biosimilars Drug Models, Specifications and Application

9.10.4 3SBIO Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.10.5 3SBIO Recent Developments

9.11 Luye Pharma

9.11.1 Luye Pharma Company Information, Head Office, Market Area and Industry Position

9.11.2 Luye Pharma Company Profile and Main Business

9.11.3 Luye Pharma Biosimilars Drug Models, Specifications and Application

9.11.4 Luye Pharma Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.11.5 Luye Pharma Recent Developments

9.12 Celltrion

9.12.1 Celltrion Company Information, Head Office, Market Area and Industry Position

9.12.2 Celltrion Company Profile and Main Business

9.12.3 Celltrion Biosimilars Drug Models, Specifications and Application

9.12.4 Celltrion Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.12.5 Celltrion Recent Developments

9.13 Pfizer

9.13.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.13.2 Pfizer Company Profile and Main Business

9.13.3 Pfizer Biosimilars Drug Models, Specifications and Application

9.13.4 Pfizer Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.13.5 Pfizer Recent Developments

9.14 Novartis

9.14.1 Novartis Company Information, Head Office, Market Area and Industry Position

9.14.2 Novartis Company Profile and Main Business

9.14.3 Novartis Biosimilars Drug Models, Specifications and Application

9.14.4 Novartis Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.14.5 Novartis Recent Developments

9.15 Dr Reddy’s

9.15.1 Dr Reddy’s Company Information, Head Office, Market Area and Industry Position

9.15.2 Dr Reddy’s Company Profile and Main Business

9.15.3 Dr Reddy’s Biosimilars Drug Models, Specifications and Application

9.15.4 Dr Reddy’s Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.15.5 Dr Reddy’s Recent Developments

9.16 Celgen Biopharma

9.16.1 Celgen Biopharma Company Information, Head Office, Market Area and Industry Position

9.16.2 Celgen Biopharma Company Profile and Main Business

9.16.3 Celgen Biopharma Biosimilars Drug Models, Specifications and Application

9.16.4 Celgen Biopharma Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.16.5 Celgen Biopharma Recent Developments

9.17 Eli Lilly

9.17.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position

9.17.2 Eli Lilly Company Profile and Main Business

9.17.3 Eli Lilly Biosimilars Drug Models, Specifications and Application

9.17.4 Eli Lilly Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.17.5 Eli Lilly Recent Developments

9.18 Sanofi

9.18.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.18.2 Sanofi Company Profile and Main Business

9.18.3 Sanofi Biosimilars Drug Models, Specifications and Application

9.18.4 Sanofi Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.18.5 Sanofi Recent Developments

9.19 Geropharm

9.19.1 Geropharm Company Information, Head Office, Market Area and Industry Position

9.19.2 Geropharm Company Profile and Main Business

9.19.3 Geropharm Biosimilars Drug Models, Specifications and Application

9.19.4 Geropharm Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.19.5 Geropharm Recent Developments

9.20 Biocon

9.20.1 Biocon Company Information, Head Office, Market Area and Industry Position

9.20.2 Biocon Company Profile and Main Business

9.20.3 Biocon Biosimilars Drug Models, Specifications and Application

9.20.4 Biocon Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.20.5 Biocon Recent Developments

9.21 Wockhardt

9.21.1 Wockhardt Company Information, Head Office, Market Area and Industry Position

9.21.2 Wockhardt Company Profile and Main Business

9.21.3 Wockhardt Biosimilars Drug Models, Specifications and Application

9.21.4 Wockhardt Biosimilars Drug Revenue and Gross Margin, 2018-2023

9.21.5 Wockhardt Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Biosimilars Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Biosimilars Drug Market Restraints

Table 3. Biosimilars Drug Market Trends

Table 4. Biosimilars Drug Industry Policy

Table 5. Global Biosimilars Drug Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Biosimilars Drug Revenue Market Share by Company (2018-2023)

Table 7. Global Biosimilars Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Biosimilars Drug Mergers & Acquisitions, Expansion Plans

Table 9. Global Biosimilars Drug Manufacturers Product Type

Table 10. China Biosimilars Drug Revenue by Company (2018-2023) & (US$ million)

Table 11. China Biosimilars Drug Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Biosimilars Drug Upstream (Raw Materials)

Table 13. Global Biosimilars Drug Typical Customers

Table 14. Biosimilars Drug Typical Distributors

Table 15. By Type, Global Biosimilars Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Biosimilars Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Biosimilars Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Biosimilars Drug Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Biosimilars Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Biosimilars Drug Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Biosimilars Drug Revenue Market Share, 2018-2029

Table 22. Qilu Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 23. Qilu Pharmaceutical Company Profile and Main Business

Table 24. Qilu Pharmaceutical Biosimilars Drug Models, Specifications and Application

Table 25. Qilu Pharmaceutical Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 26. Qilu Pharmaceutical Recent Developments

Table 27. Bio-Thera Company Information, Head Office, Market Area and Industry Position

Table 28. Bio-Thera Company Profile and Main Business

Table 29. Bio-Thera Biosimilars Drug Models, Specifications and Application

Table 30. Bio-Thera Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 31. Bio-Thera Recent Developments

Table 32. Zhejiang Hisun Company Information, Head Office, Market Area and Industry Position

Table 33. Zhejiang Hisun Company Profile and Main Business

Table 34. Zhejiang Hisun Biosimilars Drug Models, Specifications and Application

Table 35. Zhejiang Hisun Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 36. Zhejiang Hisun Recent Developments

Table 37. Shanghai Henlius Company Information, Head Office, Market Area and Industry Position

Table 38. Shanghai Henlius Company Profile and Main Business

Table 39. Shanghai Henlius Biosimilars Drug Models, Specifications and Application

Table 40. Shanghai Henlius Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 41. Shanghai Henlius Recent Developments

Table 42. Innovent Biologics Company Information, Head Office, Market Area and Industry Position

Table 43. Innovent Biologics Company Profile and Main Business

Table 44. Innovent Biologics Biosimilars Drug Models, Specifications and Application

Table 45. Innovent Biologics Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 46. Innovent Biologics Recent Developments

Table 47. Jiangsu Hengrui Company Information, Head Office, Market Area and Industry Position

Table 48. Jiangsu Hengrui Company Profile and Main Business

Table 49. Jiangsu Hengrui Biosimilars Drug Models, Specifications and Application

Table 50. Jiangsu Hengrui Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 51. Jiangsu Hengrui Recent Developments

Table 52. Gan&Lee Company Information, Head Office, Market Area and Industry Position

Table 53. Gan&Lee Company Profile and Main Business

Table 54. Gan&Lee Biosimilars Drug Models, Specifications and Application

Table 55. Gan&Lee Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 56. Gan&Lee Recent Developments

Table 57. Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position

Table 58. Tonghua Dongbao Company Profile and Main Business

Table 59. Tonghua Dongbao Biosimilars Drug Models, Specifications and Application

Table 60. Tonghua Dongbao Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 61. Tonghua Dongbao Recent Developments

Table 62. United Laboratory Company Information, Head Office, Market Area and Industry Position

Table 63. United Laboratory Company Profile and Main Business

Table 64. United Laboratory Biosimilars Drug Models, Specifications and Application

Table 65. United Laboratory Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 66. United Laboratory Recent Developments

Table 67. 3SBIO Company Information, Head Office, Market Area and Industry Position

Table 68. 3SBIO Company Profile and Main Business

Table 69. 3SBIO Biosimilars Drug Models, Specifications and Application

Table 70. 3SBIO Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 71. 3SBIO Recent Developments

Table 72. Luye Pharma Company Information, Head Office, Market Area and Industry Position

Table 73. Luye Pharma Company Profile and Main Business

Table 74. Luye Pharma Biosimilars Drug Models, Specifications and Application

Table 75. Luye Pharma Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 76. Luye Pharma Recent Developments

Table 77. Celltrion Company Information, Head Office, Market Area and Industry Position

Table 78. Celltrion Company Profile and Main Business

Table 79. Celltrion Biosimilars Drug Models, Specifications and Application

Table 80. Celltrion Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 81. Celltrion Recent Developments

Table 82. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 83. Pfizer Company Profile and Main Business

Table 84. Pfizer Biosimilars Drug Models, Specifications and Application

Table 85. Pfizer Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 86. Pfizer Recent Developments

Table 87. Novartis Company Information, Head Office, Market Area and Industry Position

Table 88. Novartis Company Profile and Main Business

Table 89. Novartis Biosimilars Drug Models, Specifications and Application

Table 90. Novartis Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 91. Novartis Recent Developments

Table 92. Dr Reddy’s Company Information, Head Office, Market Area and Industry Position

Table 93. Dr Reddy’s Company Profile and Main Business

Table 94. Dr Reddy’s Biosimilars Drug Models, Specifications and Application

Table 95. Dr Reddy’s Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 96. Dr Reddy’s Recent Developments

Table 97. Celgen Biopharma Company Information, Head Office, Market Area and Industry Position

Table 98. Celgen Biopharma Company Profile and Main Business

Table 99. Celgen Biopharma Biosimilars Drug Models, Specifications and Application

Table 100. Celgen Biopharma Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 101. Celgen Biopharma Recent Developments

Table 102. Eli Lilly Company Information, Head Office, Market Area and Industry Position

Table 103. Eli Lilly Company Profile and Main Business

Table 104. Eli Lilly Biosimilars Drug Models, Specifications and Application

Table 105. Eli Lilly Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 106. Eli Lilly Recent Developments

Table 107. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 108. Sanofi Company Profile and Main Business

Table 109. Sanofi Biosimilars Drug Models, Specifications and Application

Table 110. Sanofi Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 111. Sanofi Recent Developments

Table 112. Geropharm Company Information, Head Office, Market Area and Industry Position

Table 113. Geropharm Company Profile and Main Business

Table 114. Geropharm Biosimilars Drug Models, Specifications and Application

Table 115. Geropharm Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 116. Geropharm Recent Developments

Table 117. Biocon Company Information, Head Office, Market Area and Industry Position

Table 118. Biocon Company Profile and Main Business

Table 119. Biocon Biosimilars Drug Models, Specifications and Application

Table 120. Biocon Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 121. Biocon Recent Developments

Table 122. Wockhardt Company Information, Head Office, Market Area and Industry Position

Table 123. Wockhardt Company Profile and Main Business

Table 124. Wockhardt Biosimilars Drug Models, Specifications and Application

Table 125. Wockhardt Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 126. Wockhardt Recent Developments

List of Figure

Figure 1. Biosimilars Drug Picture

Figure 2. Global Biosimilars Drug Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Biosimilars Drug Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Biosimilars Drug Market Share of Global

Figure 5. Global Biosimilars Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Biosimilars Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Biosimilars Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Biosimilars Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Biosimilars Drug Industry Chain

Figure 10. Monoclonal Antibodies

Figure 11. Insulin

Figure 12. Others

Figure 13. By Type, Global Biosimilars Drug Revenue, 2018-2029, US$ Million

Figure 14. By Type, Global Biosimilars Drug Revenue Market Share, 2018-2029

Figure 15. Hospital

Figure 16. Retail Pharmacy

Figure 17. Other

Figure 18. By Application, Global Biosimilars Drug Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global Biosimilars Drug Revenue Market Share, 2018-2029

Figure 20. By Region, Global Biosimilars Drug Revenue Market Share, 2018-2029

Figure 21. North America Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Biosimilars Drug Revenue Market Share, 2018-2023

Figure 23. Europe Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Biosimilars Drug Revenue Market Share, 2018-2023

Figure 25. Asia Pacific Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Biosimilars Drug Revenue Market Share, 2018-2023

Figure 27. South America Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Biosimilars Drug Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. Biosimilars Drug Market Share, 2018-2023

Figure 32. By Type, U.S. Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 34. Europe Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe Biosimilars Drug Market Share, 2018-2023

Figure 36. By Type, Europe Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 38. China Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China Biosimilars Drug Market Share, 2018-2023

Figure 40. By Type, China Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 42. Japan Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan Biosimilars Drug Market Share, 2018-2023

Figure 44. By Type, Japan Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea Biosimilars Drug Market Share, 2018-2023

Figure 48. By Type, South Korea Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia Biosimilars Drug Market Share, 2018-2023

Figure 52. By Type, Southeast Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 54. India Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India Biosimilars Drug Market Share, 2018-2023

Figure 56. By Type, India Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia Biosimilars Drug Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)